Results 211 to 220 of about 103,477 (258)
Genetic Characterization of MODY in Iranian Families Using Multigenerational-Based Whole-Exome Sequencing Approach. [PDF]
Sefid F +10 more
europepmc +1 more source
Identification of novel compound heterozygous mutations in the GLB1 gene by whole-exome sequencing in a case of infantile GM1 gangliosidosis: a case report. [PDF]
Zhong G +5 more
europepmc +1 more source
Movement Disorders Clinical Practice, EarlyView.
Bruno Antunes Contrucci +10 more
wiley +1 more source
Genome Variation in Alcohol Use Disorder by Whole-Exome Sequencing. [PDF]
Liu L +14 more
europepmc +1 more source
GLUT1 Deficiency Syndrome with Coexistent Movement Disorder and Anemia
Movement Disorders Clinical Practice, EarlyView.
Sangeetha Yoganathan +12 more
wiley +1 more source
Short report: Targeted analysis of whole exome sequencing data in Indian cryptogenic stroke patients. [PDF]
Dev P +4 more
europepmc +1 more source
Expanding the Phenotype of PARK‐PRKN to Spastic Paraplegia: A Report of Two Cases
Movement Disorders Clinical Practice, EarlyView.
Nicolas Geoffre +5 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Dermatitis®, 2013
Our goal is to highlight annually a methodology of significance to the journal’s domains, either because it has been used clinically or researchwise for our fields of interest or because it holds promise as a tool in diagnosing, treating, or investigating corresponding diseases.
Donald A, Glass, And Anthony A, Nuara
openaire +4 more sources
Our goal is to highlight annually a methodology of significance to the journal’s domains, either because it has been used clinically or researchwise for our fields of interest or because it holds promise as a tool in diagnosing, treating, or investigating corresponding diseases.
Donald A, Glass, And Anthony A, Nuara
openaire +4 more sources
Patterns of Whole Exome Sequencing in Resected Cholangiocarcinoma [PDF]
Background: With minimally effective chemotherapy options, cholangiocarcinoma patients have 5 year survival rate of 10%. Tumor genetic profiling (TGP) can identify mutations susceptible to targeted therapies. We sought to describe the use of TGP and frequency of actionable results in resected cholangiocarcinoma.
Daneng Li +2 more
exaly +3 more sources

